| Drug Name: | Sparfloxacin (110871-86-8) |
|---|---|
| PubChem ID: | 60464 |
| SMILES: | C[C@@H]1CN(C[C@@H](N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F |
| InchiKey: | DZZWHBIBMUVIIW-DTORHVGOSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 392.406 |
| LogP | : | 2.0816 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 100.59 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Amiodarone (1951-25-3) | Torsade De Pointes | Additive | Not established | Overview of electrocardiographic and cardiovascular safety data for sparfloxacin Sparfloxacin Safety Group |
| Terfenadine (50679-08-8) | Torsade De Pointes | Additives | Additive effect of drug | The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|